2022
DOI: 10.1007/s12015-022-10435-8
|View full text |Cite
|
Sign up to set email alerts
|

Induced Pluripotent Stem Cell-Derived Corneal Cells: Current Status and Application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 121 publications
0
3
0
Order By: Relevance
“…Perinatal stem cells, including amniotic fluid stem cells, exhibit multipotent differentiation capabilities. Additionally, umbilical cord blood stem cells are employed in hematopoietic stem cell transplantation, while cord tissue stem cells (mesenchymal stem cells), dental pulp stem cells (multipotent stem cells), and ADSCs are also notable sources [11][12][13][14][15][16][17][18][19]. Several concerns have been raised regarding the procurement of human embryonic stem cells.…”
Section: Introductionmentioning
confidence: 99%
“…Perinatal stem cells, including amniotic fluid stem cells, exhibit multipotent differentiation capabilities. Additionally, umbilical cord blood stem cells are employed in hematopoietic stem cell transplantation, while cord tissue stem cells (mesenchymal stem cells), dental pulp stem cells (multipotent stem cells), and ADSCs are also notable sources [11][12][13][14][15][16][17][18][19]. Several concerns have been raised regarding the procurement of human embryonic stem cells.…”
Section: Introductionmentioning
confidence: 99%
“…Guiding human pluripotent stem cells (hPSCs) toward specific cell types such as LSCs possesses significant promise for treating patients needing LSC transplants. Major advantages of hPSCs as the LSC source include abundance and donor-independent “off-the-shelf” nature, and, to this day, multiple CE/LSC differentiation methods for hPSCs have been introduced ( Mahmood et al., 2022 ). Aiming to facilitate clinical translation, protocols have shifted toward simplified feeder- and serum-free versions such as our own ( Hongisto et al., 2017 ; Mikhailova et al., 2014 ).…”
Section: Introductionmentioning
confidence: 99%
“…Corneal limbal stem cell (LSC)-driven repair mechanisms and homeostatic renewal of corneal epithelium (CE) are essential processes in the maintenance of human ocular surface health and clarity (Deng et al, 2019). Guiding human pluripotent stem cells (hPSCs) toward specific cell types such as LSCs possesses significant promise in translational applications and could be used for ocular surface regeneration for patients suffering from bilateral limbal stem cell deficiency (LSCD) (Ghareeb et al, 2020; Mahmood et al, 2022). Major advantages of hPSCs as the LSC source include abundance and donor-independent “off-the-shelf” nature, and to this day, multiple CE/LSC differentiation methods for hPSCs have been introduced (Mahmood et al, 2022).…”
Section: Introductionmentioning
confidence: 99%
“…Guiding human pluripotent stem cells (hPSCs) toward specific cell types such as LSCs possesses significant promise in translational applications and could be used for ocular surface regeneration for patients suffering from bilateral limbal stem cell deficiency (LSCD) (Ghareeb et al, 2020; Mahmood et al, 2022). Major advantages of hPSCs as the LSC source include abundance and donor-independent “off-the-shelf” nature, and to this day, multiple CE/LSC differentiation methods for hPSCs have been introduced (Mahmood et al, 2022). In an attempt to facilitate their clinical translation, some protocols have progressed from traditional reliance on conditioned media, feeder cells and/or serum (e.g.…”
Section: Introductionmentioning
confidence: 99%